Home » CBER: Speed US Biologic Review With Proper Application Format
CBER: Speed US Biologic Review With Proper Application Format
December 17, 2009
Biologics makers may accelerate U.S. Food and Drug Administration (FDA) reviews if they submit documents in the correct binding and format detailed in
new standard operating procedures and policies (SOPP) for the FDA’s Center for Biologics Evaluation and Research (CBER) staff.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor